August 30, 2014 6:16 PM ET

Pharmaceuticals

Company Overview of GlaxoSmithKline plc, 17 Consumer OTC Healthcare Brands

Company Overview

As of March 30, 2012, 17 Consumer OTC Healthcare Brands of GlaxoSmithKline plc were acquired by Prestige Brands Holdings, Inc. GlaxoSmithKline plc, 17 Consumer OTC Healthcare Brands comprises 17 over-the-counter (OTC) pharmaceutical brands including, BC, Goody's, and Ecotrin brands of pain relievers; Beano, Gaviscon, Phazyme, Tagamet, and Fiber Choice GI brands; and the Sominex sleep aid brand. The asset is located in the United States.

,  

United States

Key Executives for GlaxoSmithKline plc, 17 Consumer OTC Healthcare Brands

GlaxoSmithKline plc, 17 Consumer OTC Healthcare Brands does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Selexagen Therapeutics, Inc. United States
QOL Medical, LLC United States
CTI Technologies Inc. United States
Predict, Inc. United States
Energy Factors Inc United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GlaxoSmithKline plc, 17 Consumer OTC Healthcare Brands, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.